Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Laato

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Anatomical Science International|June 18, 2005
Expression of insulin receptor substrates 1-3, glucose transporters GLUT-1-4, signal regulatory protein 1alpha, phosphatidylinositol 3-kinase and protein kinase B at the protein level in the human testisKersti Kokk, Esko Veräjänkorva, Matti Laato, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 22, 2012
Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinomaAdam Elzagheid, Abdelbaset Buhmeida, Matti Laato, et al.
The European Journal of Surgery = Acta Chirurgica|July 13, 2002
Prognostic value of various staging and grading systems in proximal colon cancerMarja Hilska, Yrjö Collan, Peter J Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patientsTeemu T Junttila, Matti Laato, Tero Vahlberg, et al.
Cancer Investigation|December 17, 2009
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patientsRiyad Bendardaf, Abdelbaset Buhmeida, Marja Hilska, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 30, 2011
[Update on current care guidelines: urinary tract infections]Maarit Wuorela, Timo Kouri, Matti Laato, et al.
Journal of Gastrointestinal Cancer|November 19, 2009
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinomaAbdelbaset Buhmeida, Riyad Bendardaf, Marja Hilska, et al.
Anticancer Research|February 6, 2009
VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survivalRiyad Bendardaf, Abdelbaset Buhmeida, Marja Hilska, et al.
Urologic Oncology|December 3, 2014
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomyHeikki Seikkula, Kari T Syvänen, Samu Kurki, et al.
Plos One|October 23, 2013
Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignanciesAnnele Sainio, Marie Nyman, Riikka Lund, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Anatomical Science International|June 18, 2005
Expression of insulin receptor substrates 1-3, glucose transporters GLUT-1-4, signal regulatory protein 1alpha, phosphatidylinositol 3-kinase and protein kinase B at the protein level in the human testisKersti Kokk, Esko Veräjänkorva, Matti Laato, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 22, 2012
Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinomaAdam Elzagheid, Abdelbaset Buhmeida, Matti Laato, et al.
The European Journal of Surgery = Acta Chirurgica|July 13, 2002
Prognostic value of various staging and grading systems in proximal colon cancerMarja Hilska, Yrjö Collan, Peter J Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patientsTeemu T Junttila, Matti Laato, Tero Vahlberg, et al.
Cancer Investigation|December 17, 2009
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patientsRiyad Bendardaf, Abdelbaset Buhmeida, Marja Hilska, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 30, 2011
[Update on current care guidelines: urinary tract infections]Maarit Wuorela, Timo Kouri, Matti Laato, et al.
Journal of Gastrointestinal Cancer|November 19, 2009
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinomaAbdelbaset Buhmeida, Riyad Bendardaf, Marja Hilska, et al.
Anticancer Research|February 6, 2009
VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survivalRiyad Bendardaf, Abdelbaset Buhmeida, Marja Hilska, et al.
Urologic Oncology|December 3, 2014
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomyHeikki Seikkula, Kari T Syvänen, Samu Kurki, et al.
Plos One|October 23, 2013
Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignanciesAnnele Sainio, Marie Nyman, Riikka Lund, et al.
Pageof 3